Results 81 to 90 of about 742,048 (314)

216 Jewish Hospital of St. Louis [PDF]

open access: yes, 1959
https://digitalcommons.wustl.edu/bjc_216/1044/thumbnail ...

core   +1 more source

Okanin Suppresses the Growth of Colorectal Cancer Cells by Targeting at Peroxiredoxin 5

open access: yesAdvanced Science, EarlyView.
Okanin suppresses colorectal cancer growth by directly targeting PRDX5. This natural compound selectively binds peroxiredoxin 5 (PRDX5), inhibiting its activity and inducing WSB1‐mediated degradation. PRDX5 loss elevates ROS, suppresses GPX4 via SIAH2, and further triggers cell death (apoptosis and ferroptosis).
Ji Zhong Zhao   +9 more
wiley   +1 more source

Know your HIV epidemic (KYE) report: review of the HIV epidemic in South Africa.

open access: yes, 2011
In order to update and consolidate South Africa’s evidence base for HIV-prevention interventions, it was decided by the Government of South Africa to commission a synthesis of the available data on the epidemiology of prevalent and incident HIV ...
Chikwava, Fadzai   +6 more
core  

Take one [PDF]

open access: yes, 1981
This item contains two issues of the Take One newsletter: September 3, and 17, 1981Take One was published every two weeks and focused on short news items and announcements "for the people of University Hospital.

core  

Lifespan‐Regulated CAR‐Macrophages from Myeloid Progenitors for Enhanced Colorectal Cancer Therapy

open access: yesAdvanced Science, EarlyView.
Using a tamoxifen‐inducible Hoxb8 system, proliferative bone marrow progenitors can be generated, which are subsequently engineered with an anti‐CEA CAR construct containing a suicide gene (iCas9) and differentiated into CAR‐macrophages. This method facilitates scale up the production of CAR‐macrophages.
Chuancheng Gao   +8 more
wiley   +1 more source

Use of recombinant antigens for the diagnosis of Chagas disease and blood bank screening [PDF]

open access: diamond, 1990
Elza Almeida   +4 more
openalex   +1 more source

MYC/TET3‐Regulated TMEM65 Activates OXPHOS‐SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple‐Negative Breast Cancer

open access: yesAdvanced Science, EarlyView.
Triple‐negative breast cancer (TNBC) remains a major challenge in breast cancer management as it lacks effective therapeutic targets. This study uncovers that MYC/TET3‐regulated mitochondrial inner‐membrane protein TMEM65 promotes TNBC progression and cisplatin resistance by activating the OXPHOS‐SERPINB3 pathway and reveals TMEM65 as a potential ...
Yin‐Ling Zhang   +10 more
wiley   +1 more source

Ultramassive transfusion and adjunctive therapies in a case of blood bank depletion. [PDF]

open access: yesTrauma Case Rep, 2023
Jackson M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy